ANGANY INC has a total of 14 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2013. It filed its patents most often in EPO (European Patent Office), Australia and Republic of Korea. Its main competitors in its focus markets biotechnology and pharmaceuticals are SHANGHAI CELL THERAPY RES INST, GRACELL BIOTECHNOLOGIES SHANGHAI CO LTD and LI HUASHUN.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | Australia | 3 | |
#3 | Republic of Korea | 2 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | Japan | 1 | |
#7 | Singapore | 1 | |
#8 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Medical preparations | |
#5 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Catala Virginie | 8 |
#2 | Faye Loïc | 7 |
#3 | Fitchette Anne-Catherine | 7 |
#4 | Gomord Véronique | 7 |
#5 | Faye Loic | 5 |
#6 | Vezina Louis-Philippe | 5 |
#7 | Fitchette Anne Catherine | 5 |
#8 | Gomord Veronique | 5 |
#9 | Véronique Gomord | 1 |
#10 | Anne-Catherine Fitchette | 1 |